Delivery Order SPE2DX22D0020-SPE2D825F37ED
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $48,274.73 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. This firm fixed-price contract, which is not set-aside, represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $70,980 on July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is set to be completed by July 23, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,090.00 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, which is not set-aside, represents a child delivery order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $27,999.27 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company serves as a critical pharmaceutical distributor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,244.37 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract, awarded without set-aside designation through competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,320.93 by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, with an ultimate completion date of July 28, 2025. This contract, issued under firm fixed-price terms with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,713.12 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,936.12 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $304,458.20 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D825F37EDDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $938,061.02 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by July 28, 2025, with performance taking place at the company's Corporate Office location in Conshohocken, PA. This award continues AmerisourceBergen Drug Corp's role as a critical pharmaceutical vendor for federal military and veteran healthcare systems. The company supplies a comprehensive range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, specialized therapeutics, medical devices, and related healthcare commodities—to support Defense Health Agency, U.S. Coast Guard, and other government healthcare operations. The contract is structured as part of the DLA's pharmaceutical procurement strategy, which is transitioning to the Pharmaceutical Prime Vendor Global Program Generation V model involving multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $938.1k | 7/26/25 |